New guidelines cover theranostics for brain tumors
AuntMinnie
OCTOBER 14, 2024
The use of somatostatin receptor PET imaging and therapy in meningiomas is on the rise, and new guidelines on their use can help pave the way to improved outcomes for patients, experts noted in a recent article. “The application of radiolabeled [somatostatin receptor] ligands is widely considered to have high potential for improved meningioma management,” wrote lead author Nathalie Albert, MD, of the Ludwig Maximilian University of Munich, and colleagues.
Let's personalize your content